Efficacy of Adding Interleukin-2 to an Optimized Antiretroviral Regimen in HIV Patients in Therapeutic Failure (ANRS123)
Clinical trial NCT00113282 · COMPLETED
Trial details
- NCT number
- NCT00113282
- Sponsor
- French National Agency for Research on AIDS and Viral Hepatitis
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2004-06-01
- Primary completion
- 2007-12-01
- Enrollment
- 57
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.